Cryogenic Solutions for Constant Temperature Control of Vaccines.

Learn how cryogenic cold-temperature solutions, using Liquid Nitrogen and Dry Ice, have been gaining favor over mechanical refrigeration methods throughout manufacturing, storage...

Moderna starts Phase I study of new Covid-19 vaccine candidate.

Moderna Inc, pioneering messenger RNA therapeutics and vaccines, announced that the first participants have been dosed in the Phase 2/3 study...

Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy.

Tevogen Bio has entered a partnership with BioCentriq, to support clinical manufacturing of Tevogen's investigational COVID-19 treatment....

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in UK and South Africa Trials.

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced final efficacy of 96.4%...

Takeda and IDT Support Manufacturing of Johnson & Johnsons COVID-19 Vaccine.

Takeda Pharma announced a mutual agreement with IDT Biologika GmbH to utilize capacity at IDT previously reserved for Takeda's dengue vaccine candidate to manufacture the single-shot COVID-19..

Altimmune Expands AdCOVID Manufacturing Collaboration with Lonza.

Altimmune announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza.

Frost & Sullivan sees decentralization critical to success of Indias Covid-19 vaccination campaign.

Union government needs to implement multiple innovative ways to make vaccines easily accessible. decentralization of vaccination is paramount...

AstraZeneca to supply the US with up to half a million doses of the potential COVID-19 antibody treatment AZD7442.

AstraZeneca has modified an existing agreement with the US Government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody...